Provided by Tiger Trade Technology Pte. Ltd.

Madrigal Pharmaceuticals

538.71
-1.3200-0.24%
Post-market: 540.001.29+0.24%17:47 EDT
Volume:165.75K
Turnover:89.29M
Market Cap:12.42B
PE:-37.89
High:548.60
Open:540.03
Low:532.66
Close:540.03
52wk High:615.00
52wk Low:393.61
Shares:23.06M
Float Shares:13.73M
Volume Ratio:0.71
T/O Rate:1.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.2164
EPS(LYR):-12.8501
ROE:-53.31%
ROA:-17.84%
PB:23.72
PE(LYR):-41.92

Loading ...

Oct 31, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2024

Major Issues Report

Form 8-K - Current report
Sep 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Aug 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 27, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 07, 2024

Major Issues Report

Form 8-K - Current report
May 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2024

Major Issues Report

Form 8-K - Current report
Apr 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 02, 2024

Major Issues Report

Form 8-K - Current report
Apr 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities